Cutting-Edge Research for Cancer Stem Cells
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 29
Special Issue Editor
Interests: gynecological oncology; immunotherapy; cancer stem cells; drug development; molecular diagnostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer stem cells (CSCs) are a small but important group of cells within tumors which contribute to cancer growth, metastasis, relapse, and resistance to treatments. These cells can renew and adapt, playing a significant role in therapy resistance and cancer spread. Despite new treatments, CSCs can resist standard therapies, making it critical to find new ways to target them. This Special Issue invites cutting-edge research that focuses on CSC biology, utilizing techniques such as single-cell sequencing, CRISPR/Cas9, and patient-derived organoids to explore new treatment possibilities. We welcome original research and reviews on how CSCs resist treatment, interact with the immune system, and shape their tumor microenvironment, along with new therapies aimed against CSCs. Together, we hope to share new discoveries that can help advance future cancer therapies.
Dr. Suryavathi Viswanadhapalli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer stem cells
- tumor initiation
- metastasis
- self-renewal
- therapy resistance
- single-cell sequencing
- patient-derived organoids
- CRISPR/Cas9
- small molecules
- monoclonal antibodies
- CAR-T cell therapy
- tumor microenvironment
- combination therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
